![](https://3211ea.a2cdn1.secureserver.net/wp-content/uploads/2023/09/Screen-Shot-2023-09-06-at-6.49.00-PM-1024x496.png)
Frequent injections in the eye can cause infection, inflammation, and glaucoma. Akari is developing PAS-nomacopan with potential for 4 or fewer doses a year for the treatment geography atrophy (GA). Hear GA insights from Elias Reichel, M.D. at https://bit.ly/3OMMPkt $AKTX